Pelvis Adaptive Radiotherapy (ART)
Recruiting
N/A
Interventional Study
Pelvis Neoplasms
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 280 (estimated)
- Sponsor
- Royal North Shore Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Pelvis Adaptive radiotherapy (ART) is a two phase study looking at using adaptive radiotherapy to help reduce toxicity for cancer patients having radiotherapy in the pelvic region.
Adaptive radiotherapy is a new technology that provides the ability to account for daily changes in anatomy. Adaptive radiotherapy also provides a foundation for which radiotherapy margins might be safely reduced.
Pha…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Age \> 18
2. ECOG performance status 0-2
3. Patients receiving curative or adjuvant pelvic radiation including:
1. Prostate cancer where nodal treatment is required
2. Prostate cancer post prostatectomy
3. Bladder cancer
4. Rectal cancer
5. Anal cancer
6. A…
Contacts